Tag

Quest Diagnostics

All articles tagged with #quest diagnostics

health2 years ago•2 min saved

"Revolutionary Alzheimer's Blood Test Now Available to Consumers through Quest Diagnostics"

Quest Diagnostics has launched AD-Detect, the first direct-to-consumer blood test that detects abnormal levels of beta amyloid, a protein associated with Alzheimer's disease. Priced at $399, the test allows individuals aged 18 and older with mild memory loss or a family history of Alzheimer's to assess their risk for the disease. If the test is positive, users will be contacted by a doctor to discuss next steps. While the test has not undergone FDA review, it can be prescribed by a healthcare provider.

via Reuters|

#alzheimers-disease #beta-amyloid #blood-test

healthtech2 years ago•2 min saved

"Revolutionary Blood Test Allows Consumers to Assess Alzheimer's Disease Risk"

Quest Diagnostics has released the first blood test for consumer purchase that can assess the risk of developing Alzheimer's disease. The AD-Detect Test for Alzheimer's Disease costs $399 and uses plasma from a single blood draw to evaluate levels of amyloid beta proteins, which are linked to the progression of Alzheimer's disease. The test aims to detect early signs associated with the risk of developing the disease and make Alzheimer's disease risk assessment more accessible. Test results will be available on a secure patient portal.

via Fox Business|

#alzheimers-disease #amyloid-beta-proteins #blood-test

health2 years ago•1 min saved

Quest Diagnostics introduces innovative at-home blood test for early Alzheimer's detection

Quest Diagnostics has launched the first blood-based biomarker test, called AD-Detect, to assess the risk of developing Alzheimer's disease. The test evaluates the ratio of two peptides of amyloid beta in plasma, which helps assess the risk based on the brain protein's contribution to the disease. With emerging treatments and growing recognition of non-pharmacological interventions, there is increasing acceptance of blood tests for early detection. The number of Americans diagnosed with Alzheimer's is expected to reach 14 million by 2060.

via MarketWatch|

#alzheimers-disease #amyloid-beta-proteins #biomarker

business2 years ago•3 min saved

Marijuana Positive Tests in Workplace Reach 25-Year High

Positive marijuana urine tests after workplace accidents among the general U.S. workforce hit 7.3% in 2022, the highest level in 25 years, according to a Quest Diagnostics analysis. The higher percentage had a correspondence with the move by some states to make usage of marijuana legal. Quest Diagnostics found that the percentage of people in the general U.S. workforce that tested positive for marijuana came in at 4.3% in 2022, marking an increase from the prior year. The analysis also looked at how positive worker marijuana tests differed in states based on the legality status of the substance.

via Fox Business|

#business #drug-testing #legalization

business2 years ago•2 min saved

Marijuana Use Among American Workers Reaches Record High

A study by Quest Diagnostics has found that marijuana use among US workers reached "historic" highs in 2022, with 4.3% of over 6 million general workforce urine tests being positive for cannabis, up from 3.9% in 2021. The industries that saw the greatest increase in positivity rates over the past five years were hospitality and food services, retail, and finance/insurance. The study also found that 7.3% of workers who had suffered a workplace injury tested positive for marijuana in 2022, marking the highest positivity rate in 25 years.

via New York Post |

#business #drug-testing #marijuana